Kura Oncology (KURA) Non-cash Items (2015 - 2026)

Kura Oncology (KURA) has 12 years of Non-cash Items data on file, last reported at $51.8 million in Q1 2026.

• Non-cash Items for Q1 2026 came in at $51.8 million, up 9.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $51.8 million (up 9.75% YoY), and the FY2025 annual result was $36.6 million, down 16.82% from the prior year.
• Non-cash Items rose to $51.8 million in Q1 2026 per KURA's latest filing, from $36.6 million in the prior quarter.
• Over five years, Non-cash Items peaked at $57.5 million in Q1 2022 and troughed at $6.0 million in Q4 2023.
• A 5-year average of $44.5 million and a median of $47.2 million in 2024 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items tumbled 86.66% in 2023, then soared 638.01% in 2024.
• A 5-year view of Non-cash Items shows it stood at $44.7 million in 2022, then plunged by 86.66% to $6.0 million in 2023, then soared by 638.01% to $44.0 million in 2024, then fell by 16.82% to $36.6 million in 2025, then jumped by 41.53% to $51.8 million in 2026.
• Business Quant data shows KURA's Non-cash Items at $51.8 million in Q1 2026, $36.6 million in Q4 2025, and $41.0 million in Q3 2025.